Talk to a healthcare provider or check Noom Med to determine eligibility: Schedule an appointment with your primary care doctor, endocrinologist, or weight management specialist
Most are injectable medications, although one oral formulation is currently available
One study concluded that t wo-thirds of the weight loss was regained after one year off GLP-1
Based on general principles applicable to subcutaneous injectable therapies: Those who do not rotate injection sites adequately , leading to repeated trauma to the same area Individuals on concomitant anticoagulant therapy (for example, warfarin or direct oral anticoagulants), who may experience more pronounced bruising People with a history of allergic skin conditions , who may be more prone to localised irritation, though this has not been specifically studied for retatrutide It should be noted that risk factors relating to specific excipients or the effect of body mass index on injection site reactions cannot be confirmed at this stage, as retatrutide's final formulation details are not yet publicly available in a licensed SmPC
D., Kahn, S
Legal status for research In the United States, BPC-157 is not a controlled substance and may be legally purchased and possessed for laboratory research use
